{"name":"Motus GI Holdings, Inc.","slug":"motus","ticker":"MOTS","exchange":"NASDAQ","domain":"motusgi.com","description":"Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.","hq":"Fort Lauderdale, FL","founded":0,"employees":"15","ceo":"Mark Pomeranz","sector":"MedTech / Gastroenterology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$638","metrics":{"revenue":327000,"revenueGrowth":14.3,"grossMargin":-24.5,"rdSpend":3467000,"netIncome":-12867000,"cash":4958000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Motus GI Holdings Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Motus GI Holdings reported its financial results for the fourth quarter and full year 2023, with revenue of $1.1 million and a net loss of $6.3 million.","drugName":"","sentiment":"neutral"},{"date":"2023-11-14","type":"deal","headline":"Motus GI Holdings Announces $10 Million Registered Direct Offering","summary":"Motus GI Holdings announced a registered direct offering of $10 million in gross proceeds to support its business development and growth initiatives.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2024-07-31","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC","headline":"Material Event (8-K)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1uV0dpNnQ3LTkzUHZMOFZ2S3U1TlBYcENESy0ydXRBdmdObVN2alpNb1o5dUR6RUFGbmRyVEQ0ZVpKTnQyMkpTWnFjNUtwUGJJbFE?oc=5","date":"2020-08-13","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Acutus Medical, Inc. (AFIB) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Acutus Medical, Inc. (AFIB) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1Wc1NsVVRGVnU0WUNUV09JbHlMYklXRndjcGdGaVF6dTFJT3lSdW03Xy1VMjJNdjY3amotSjFtRFY1Tm1JMVliWHJoam51cjhrMHc?oc=5","date":"2018-02-09","type":"pipeline","source":"Yahoo Finance UK","summary":"Motus GI Holdings, Inc. (MOTS) stock price, news, quote and history - Yahoo Finance UK","headline":"Motus GI Holdings, Inc. (MOTS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE9IbU9yYVJNeG45U0hKZE5oSU9OVnZyU1lUU3FBbzVDVTZyMFhCSmxCM2dKek5URUV6YmJmQ1dpYW45NzNCV1VQMldoRHVmLU5xQUE?oc=5","date":"2018-02-09","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Motus GI Holdings, Inc. (MOTS) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Motus GI Holdings, Inc. (MOTS) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Boston Scientific Corporation","Medtronic plc","Cook Medical"],"therapeuticFocus":["Gastrointestinal (GI) diseases","Endoscopy"],"financials":{"source":"sec_edgar+yahoo","revenue":319000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":319000,"period":"2023-12-31"},{"value":592000,"period":"2022-12-31"},{"value":391000,"period":"2021-12-31"},{"value":98000,"period":"2020-12-31"},{"value":107000,"period":"2019-12-31"},{"value":36000,"period":"2018-12-31"}],"grossProfit":-29000,"grossProfitHistory":[{"period":"2023-12-31","value":-250000},{"period":"2022-12-31","value":-204000},{"period":"2021-12-31","value":-233000}],"rdSpend":3467000,"rdSpendHistory":[{"period":"2023-12-31","value":3467000},{"period":"2022-12-31","value":5611000},{"period":"2021-12-31","value":5341000}],"sgaSpend":8190000,"operatingIncome":-11907000,"operatingIncomeHistory":[{"period":"2023-12-31","value":-11907000},{"period":"2022-12-31","value":-17851000},{"period":"2021-12-31","value":-17924000}],"netIncome":-12867000,"netIncomeHistory":[{"period":"2023-12-31","value":-12867000},{"period":"2022-12-31","value":-18597000},{"period":"2021-12-31","value":-19033000}],"eps":-15.89,"epsHistory":[{"period":"2023-12-31","value":-15.89},{"period":"2022-12-31","value":-86.1},{"period":"2021-12-31","value":-162}],"cash":4958000,"cashHistory":[{"period":"2023-12-31","value":4958000},{"period":"2022-12-31","value":14042000},{"period":"2021-12-31","value":22563000}],"totalAssets":7223000,"totalLiabilities":4536000,"totalDebt":2468000,"equity":2687000,"operatingCashflow":-11194000,"operatingCashflowHistory":[{"period":"2023-12-31","value":-11194000},{"period":"2022-12-31","value":-17467000},{"period":"2021-12-31","value":-14422000}],"capex":-104000,"capexHistory":[{"period":"2023-12-31","value":-104000},{"period":"2022-12-31","value":-224000},{"period":"2021-12-31","value":-470000}],"freeCashflow":-11298000,"dividendsPaid":null,"buybacks":-12000,"employees":15,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":0,"previousClose":0,"fiftyTwoWeekHigh":0.1,"fiftyTwoWeekLow":0,"fiftyTwoWeekRange":"1.0E-5 - 0.1","fiftyDayAverage":0,"twoHundredDayAverage":0,"beta":3.52,"enterpriseValue":-2505423,"forwardPE":0,"priceToBook":0,"priceToSales":0,"enterpriseToRevenue":-7.66,"enterpriseToEbitda":0.27,"pegRatio":0,"ebitda":-9145000,"ebitdaMargin":0,"freeCashflow":-4403000,"operatingCashflow":-8415000,"totalDebt":2438000,"debtToEquity":79.5,"currentRatio":1.74,"returnOnAssets":-62,"returnOnEquity":-1069,"analystRating":"","recommendationKey":"none","numberOfAnalysts":0,"targetMeanPrice":0,"targetHighPrice":0,"targetLowPrice":0,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":0,"institutionHeldPercent":5.3,"sharesOutstanding":6388876,"floatShares":5767780,"sharesShort":23242,"shortRatio":0.14,"shortPercentOfFloat":0.4,"epsTrailing":-2.96,"epsForward":-17.56,"revenuePerShare":0.06,"bookValue":0.59,"officers":[{"age":50,"name":"Ms. Ravit  Ram","title":"CFO & VP of Global Operations"},{"age":41,"name":"Mr. Elad  Amor","title":"Chief Accounting Officer"},{"age":null,"name":"Jeff  Varsalone","title":"President & Director"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.motusgi.com","phone":"954 541 8000"}}